Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of epinephrine-containing lidocaine versus mepivacaine on blood glucose level during dental local anesthesia
IRCT20181114041651N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lidocaine, mepivacaine and epinephrine (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Blood glucose level and Glucose level variation between groups. Started Oct 2022; status: completed.
02
Drugs
lidocainemepivacaineepinephrine
Beyond the preview
Go deeper on IRCT20181114041651N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181114041651N1.